Home › Migraine › North Carolina
Migraine clinical trials in North Carolina
12 studies for Migraine are looking for participants at sites in North Carolina.
Cities in North Carolina
Study of EVO756 in Adults With Migraine
- Asheville Neurology Specialists, Pa, Asheville
- Eximia Research NC, Raleigh
RecruitingPhase 2
Ages 18 to 64 · All sexes · Updated Oct 2, 2026 · NCT07616128A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Accellacare - Piedmont, Statesville
- Accellacare of Piedmont HealthCare, Statesville
- Accellacare US Inc., Winston-Salem
RecruitingPhase 1
Ages 6 to 11 · All sexes · Updated Sep 28, 2026 · NCT06995729Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- OnSite Clinical Solutions, LLC, Charlotte
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- OnSite Clinical Solutions, LLC, Charlotte
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT04649242Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Onsite Clinical Solutions Park Cedar Dr., Charlotte
- Onsite Clinical Solutions Mecklenburg, Charlotte
- Onsite Clinical Solutions Ballantyne, Charlotte
- and 2 more
RecruitingPhase 4
Ages 18 to 70 · All sexes · Updated Sep 16, 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Onsite Clinical Solutions - Don Lochman Lane - Charlotte /ID# 282834, Charlotte
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 14, 2026 · NCT05125302A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine
- Queen City Clinical Research, PLLC, Charlotte
Recruiting
Ages 22 to 84 · All sexes · Updated Aug 28, 2026 · NCT07719608A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- OnSite Clinical Solutions, Charlotte
- Guildford Neurologic Research Partners, LLC, Greensboro
- Headache Wellness Center, Greensboro
- and 2 more
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 20, 2026 · NCT07645924BE WELL With Migraine: Brain Education and WELLness With Migraine
- Wake Forest University Health Sciences, Winston-Salem
Recruiting
Ages 18 and older · All sexes · Updated Jun 12, 2026 · NCT05987592Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
- Evidera, a PPD business unit, Wilmington
RecruitingObservational study
Ages 0 and older · Women · Updated May 5, 2026 · NCT05046613Observational Study to Assess Adverse Events When Adult Female Participants Are Treated With Ubrelvy (Ubrogepant) or Qulipta (Atogepant) During Pregnancy
- Iqvia /Id# 266904, Durham
RecruitingObservational study
Ages 18 and older · Women · Updated Dec 15, 2025 · NCT05158894Aimovig Pregnancy Exposure Registry
- IQVIA Virtual Site, Durham
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 99 · Women · Updated Nov 4, 2025 · NCT06150781From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.